Masood Khosravani

765 citations
24 papers · 590 indexed · h-index 14
Topics
Nanoparticle-Based Drug Delivery (14 papers)Graphene and Nanomaterials Applications (7 papers)Advanced Drug Delivery Systems (7 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsJournal of Controlled Release
Partner nations
IranChinaUnited States

In The Last Decade

Masood Khosravani

24 papers receiving 583 citations

Peers

Masood Khosravani
Comparison fields: 5 of 80
  • Biomaterials 326
  • Biomedical Engineering 234
  • Molecular Biology 173
  • Pharmaceutical Science 130
  • Materials Chemistry 76
Replace Jacob D. Ramsey with:
Jacob D. Ramsey United States
Poornima Agrawal India
Fatemeh Sadat Tabatabaei Mirakabad Iran
Duhyeong Hwang United States
Taskeen Iqbal Janjua Australia
Ritu Kudarha India
Reyhaneh Varshochian Iran
Sunhui Chen China
Inmaculada Conejos‐Sánchez Spain
Hussaini Syed Sha Qhattal United States
Masood Khosravani relative to Jacob D. Ramsey United States Jacob D. Ramsey's profile →
Citations per field
00.5×11×
Jacob D. Ramsey · 1×
Citations per year

Countries citing papers authored by Masood Khosravani

Since Specialization
Citations

This map shows the geographic impact of Masood Khosravani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masood Khosravani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masood Khosravani more than expected).

Fields of papers citing papers by Masood Khosravani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masood Khosravani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masood Khosravani. The network helps show where Masood Khosravani may publish in the future.

Co-authorship network of co-authors of Masood Khosravani

This figure shows the co-authorship network connecting the top 25 collaborators of Masood Khosravani. A scholar is included among the top collaborators of Masood Khosravani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masood Khosravani. Masood Khosravani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 12
3 18
4 9
5 2
6 44
7 12
8 33
9 20
10 62
11 11
12 30
13 29
14 15
15 40
16 70
17
Construction of a Recombinant Phage-vaccine Capable of Reducing the Growth Rate of an Established LL2 Tumor Model.
12
18 32
19 4
20 63

About Masood Khosravani

Masood Khosravani is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Medicine, having authored 24 papers that have together received 590 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (14 papers), Graphene and Nanomaterials Applications (7 papers) and Advanced Drug Delivery Systems (7 papers). The work is most often cited by research in Biomaterials (326 citations), Pharmaceutical Science (130 citations) and Molecular Medicine (43 citations). Masood Khosravani has collaborated with scholars based in Iran, China and United States. Frequent co-authors include Mahdi Adabi, Fatemeh Madani, Seyedeh Sara Esnaashari, Thomas J. Webster, Esmaeil Sadroddiny, Hassan Maleki, Mohsen Adabi, Farid Abedin Dorkoosh, Husam M. Younes and Maria Camilla Bergonzi. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026